7月 2026
- 首頁
- Route 92 Medical, Inc.
7月 2026Route 92 Medical, Inc.的市場佔有率分析
SAN MATEO, Calif., May 06, 2025 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced that the dispute between Route 92 Medical and Q’Apel Medical has been resolved. Route 92 Medical initially filed suit against Q’Apel Medical in the U.S. […]
Route 92 Medical, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- route92medical.com
Route 92 Medical, Inc.截至 7月 2026 的總收入為 5M - 10M
Route 92 Medical, Inc. 熱門網域產生的總收入
Route 92 Medical, Inc. 熱門網域 3 年內的總收入
Route 92 Medical, Inc. 熱門網域的總收入
Route 92 Medical, Inc.的熱門網域總造訪量
了解Route 92 Medical, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Route 92 Medical, Inc.的熱門網域平均造訪時長
分析Route 92 Medical, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Route 92 Medical, Inc.的熱門網域平均頁面瀏覽量
了解Route 92 Medical, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Route 92 Medical, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Route 92 Medical, Inc. hired Raj Denhoy as Chief Financial Officer on May 18th '26.WEST JORDAN, Utah, May 18, 2026 (GLOBE NEWSWIRE) - Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Raj Denhoy to the role of Chief Financial Officer (CFO) effective today.
5月 18, 2026閱讀更多
新聞Route 92 Medical, Inc. closed offices in San Mateo, California, United States, Northern America, Americas on Dec 31st '22.Route 92 Medical Inc. announced in late 2022 it would put a 40,000-square-foot manufacturing operation in West Jordan and recently announced the headquarters move from San Mateo, California, after receiving a Utah state incentive for the $5 million expansion project.
4月 10, 2026閱讀更多
新聞Route 92 Medical, Inc. received financing of $50M in Series F on Sep 1st '24.In September 2024, Route 92 Medical secured $50m as part of a Series F financing round aimed at supporting the global commercialisation of its FreeClimb and Tenzing devices.
4月 8, 2026閱讀更多
查看所有Route 92 Medical, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
